Editorials Folic acid fortification and congenital heart disease BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b1144 (Published 13 May 2009) Cite this as: BMJ 2009;338:b1144 Article Related content Metrics Responses Peer review Related articles Research Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada Published: 13 May 2009; BMJ 338 doi:10.1136/bmj.b1673 See more Pulse oximetry may underestimate hypoxaemia in black patients, study finds BMJ December 21, 2020, 371 m4926; DOI: https://doi.org/10.1136/bmj.m4926 Partha Kar: Our approach to tackling obesity needs rethinking BMJ August 06, 2020, 370 m3034; DOI: https://doi.org/10.1136/bmj.m3034 National registry will record patient outcomes from devices implanted during vascular surgery BMJ July 24, 2020, 370 m2981; DOI: https://doi.org/10.1136/bmj.m2981 Covid-19: Data show 5000 fewer hospital admissions for acute coronary syndrome during pandemic BMJ July 15, 2020, 370 m2852; DOI: https://doi.org/10.1136/bmj.m2852 Covid-19: Pandemic is having “severe” impact on non-communicable disease care, WHO survey finds BMJ June 03, 2020, 369 m2210; DOI: https://doi.org/10.1136/bmj.m2210
